Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Abstract Text:

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Publishing Authors By Initials

For similar natural sciences: chemistry: chemistry, physical: viscosity research abstracts see: natural sciences: chemistry: chemistry, physical: viscosity research

PUBMED ID PMID:

MEDLINE DATE:

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Scandinavian journal of respiratory diseases. Supp

VOLUME: 103

Page Numbers: 130-42

Journal Abbreviation:

ISSN: 0080-6730

DAY: 25

MONTH: 02

YEAR: 1979

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 57161

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Keywords Mesh Terms:

KEYWORDS: Viscosity

MESH TERMS: physiology

Chemical & Substance for Abstract: Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. Information

Substance Name: Ipratropium

Registry Number: 60205-81-4

Grant and Affiliation Information for Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.

AFFILIATION:

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Scand J Respir Dis Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acute effects of ipratropium bromide ITBR, Sch 1000, Atrovent: a review of previous studies Related Publications

• A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens.
• Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.
• Airway hyperreactivity. Definition and short review.
• Anatomical and pathophysiological considerations in aerosol therapy.
• Anticholinergic drugs--a review.
• Bronchial hyperreactivity.
• Bronchial reactivity in occupational asthma and bronchitis.
• Bronchial reactivity in relation to occupational bronchitis and asthma.
• Chronic cough and expectoration in patients with asthma and in patients with alpha1-antitrypsin deficiency.
• Clinical implications of bronchial hyperreactivity.
• Continuous and intermittent exposure to ethanol: effect on NG 108-15 cell membrane phospholipids.
• Evaluation of ethanol effects on PLC signal transduction pathways using cell lines of neuronal origin.
• Identification and characterization of an essential telomeric repeat binding factor in fission yeast.
• Method evaluation of Fusarium DNA extraction from mycelia and wheat for down-stream real-time PCR quantification and correlation to mycotoxin levels.
• Non-specific bronchial hyperreactivity: correlation to asthma and modifying factors.
• Optimal adaptive design in clinical drug development: a simulation example.
• Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.
• Pulmonary gas exchange at rest and during exercise in chronic bronchitis.
• Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer.
• Treatment of respiratory failure.